Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.78 USD | +2.16% | -4.30% | -33.80% |
May. 07 | Transcript : AbCellera Biologics Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | AbCellera Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 40.4M | Sales 2025 * | 59.62M | Capitalization | 1.11B |
---|---|---|---|---|---|
Net income 2024 * | -175M | Net income 2025 * | -221M | EV / Sales 2024 * | 24.5 x |
Net cash position 2024 * | 120M | Net cash position 2025 * | 2M | EV / Sales 2025 * | 18.6 x |
P/E ratio 2024 * |
-6.61
x | P/E ratio 2025 * |
-6.03
x | Employees | 586 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 72.02% |
Latest transcript on AbCellera Biologics Inc.
1 day | +2.16% | ||
1 week | -4.30% | ||
1 month | -6.67% | ||
3 months | -29.21% | ||
6 months | -13.70% | ||
Current year | -33.80% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 39 | 12-11-07 | |
Founder | - | 12-11-07 | |
Carl Lars Hansen
CEO | Chief Executive Officer | 49 | 12-11-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Montalbano
BRD | Director/Board Member | 59 | 20-10-31 |
Michael Hayden
BRD | Director/Board Member | 72 | 19-09-30 |
Andrew Lo
BRD | Director/Board Member | 63 | 21-12-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.19% | 0 M€ | 0.00% | - | |
0.18% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +10.70% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 3.78 | +2.16% | 1,348,139 |
24-05-15 | 3.7 | -3.14% | 1,027,468 |
24-05-14 | 3.82 | -0.78% | 1,267,003 |
24-05-13 | 3.85 | +0.52% | 1,316,532 |
24-05-10 | 3.83 | -3.04% | 1,193,867 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.80% | 1.11B | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+48.60% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- ABCL Stock